CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma — Stella

Recruiting

Back to Mantle Cell Lymphoma trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

Germany

University Hospital of Mainz, Mainz

Klinikum der Universität München, Munich

Key details

Phase

Safety & dosing

Sponsor

Christian Schmidt, MD

Collaborators

Johannes Gutenberg University Mainz

Enrollment target

~150 participants

Started

February 2024

Primary completion

June 2031

Age range

18 Years – 75 Years

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov